JAK-Stat Pathway Reporter Stable Cell Line: HEC-1-A by Cellomics Technology
Special Features
- Origin: Grade 2, well-differentiated endometrial carcinoma
- Hormone receptor status: Estrogen receptor (ER) negative
- Growth pattern: Forms tight epithelial monolayers with distinct borders
- Usage: Suitable for both in vitro and in vivo (xenograft) tumor models
- Tumorigenic potential: Moderate in immunocompromised mice
Description
Cell Line: HEC-1-A/JAK-Stat Pathway Firefly luciferase Reporter stable cell line. Parental Line: HEC-1-A, a human endometrial adenocarcinoma cell line, is widely used in endometrial cancer research, hormone receptor signaling, and gynecologic cancer therapeutics. Growth: Adherent. Characteristics: Derived from a grade 2, well-differentiated endometrial carcinoma. Promoter: JAK-Stat Pathway Activation Responsive. Reporter: Firefly luciferase. Selection Gene: Puromycin. Safety Level: BSL-2. Shipment: Dry Ice. Storage: Liquid Nitrogen.
{"error":"Error","cart_limit":"You have too many items in your cart.","prod_limit":"You cannot add any more of this item"}